Oxidative modification of type II collagen differentially affects its arthritogenic and tolerogenic capacity in experimental arthritis

Archivum Immunologiae et Therapiae Experimentalis

Volumn 52, Issue 4, 2004, Pages 284-291

  Marcinkiewicz, Janusz ^a   Biedroń, Rafał ^a   Maresz, Katarzyna ^a   Kwaśny Krochin, Beata ^a   Bobek, Małgorzata ^a   Kontny, Ewa ^b   Maśliński, Włodzimierz ^b   Chain, Benjamin ^c  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b INSTITUTE OF RHEUMATOLOGY   (Poland)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Collagen induced arthritis; DBA 1 mice; Hypochlorous acid; Myeloperoxidase; Neutrophils; Protein oxidation

Indexed keywords

CHLORINATED COLLAGEN; CHLORINE DERIVATIVE; COLLAGEN TYPE 2; HYPOCHLORITE; MYELOPEROXIDASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CHLORINATION; COLLAGEN METABOLISM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISEASE SEVERITY; EPITOPE MAPPING; EVALUATION; EXPERIMENTAL MOUSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; INCIDENCE; INFLAMMATION; MALE; MOUSE; NEUTROPHIL; NONHUMAN; OXIDATIVE STRESS; PROTEIN MODIFICATION; REGULATORY MECHANISM; T LYMPHOCYTE ACTIVATION;

ANIMALS; ARTHRITIS, EXPERIMENTAL; COLLAGEN TYPE II; EPITOPES; HUMANS; HYPOCHLOROUS ACID; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED DBA; OXIDATION-REDUCTION; PEROXIDASE; SERUM AMYLOID A PROTEIN;

EID: 4944261959     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Backlund J., Treschow A., Bockermann R., Holm B., Holm L., Issazadeh-Navikas S., Kihlberg, J. and Holmdahl R. (2002): Glycosylation of type II collagen is of major importance for T cell tolerance and pathology in collagen-induced arthritis. Eur. J. Immunol., 32, 3776-3784.
2. Brand D. D., Myers L. K., Whittington K. B., Latham K. A., Stuart J. M., Kang A. H. and Rosloniec E. F. (2002): Detection of early changes in autoimmune T cell phenotype and function following intravenous administration of type II collagen in a TCR-transgenic model. J. Immunol., 168, 490-498.
3. Chu C. Q. and Londei M. (1999): Differential activities of immunogenic collagen type II peptides in the induction of nasal tolerance to collagen-induced arthritis. J. Autoimmun., 12, 35-42.
4. Davies J. M., Horwitz D. A. and Davies K. J. (1993): Potential roles of hypochlorous acid and N-chloroamines in collagen break-down by phagocytic cells in synovitis. Free Rad. Biol. Med., 15, 637-643.
5. Davies J. M., Horwitz D. A. and Davies K. J. (1994): Inhibition of collagenase activity by N-chlorotaurine, a product of activated neutrophils. Arthritis Rheum., 37, 424-427.
6. Edwards S. W. and Hallet M. B. (1997): Seeing the wood for the trees: the forgotten role of neutrophils in rheumatoid arthritis. Immunol. Today, 18, 320-324.
7. + T cells. Immunology, 97, 466-473.
8. Hart B. A., Bakker N., Jonker M. and Bontrop R. E. (1993): Resistance to collagen-induced arthritis in rats and rhesus monkeys after immunization with attenuated type II collagen. Eur. J. Immunol., 23, 1588-1594.
9. Kwaśny-Krochin B., Bobek M., Kontny E., Głuszko P., Biedroń R., Chain B. M., Maśliński W. and Marcinkiewicz J. (2002): Effect of taurine chloramine, the product of activated neutrophils, on the development of collagen-induced arthritis in DBA1/J mice. Amino Acids, 23, 419-426.
10. Malmstrom V., Backlund J., Jansson L., Kihlberg J. and Holmdahl R. (2000): T cells that are naturally tolerant to cartilage-derived type II collagen are involved in the development of collagen-induce arthritis. Arthritis Res., 2, 315-326.
11. Marcinkiewicz J., Chain B. M., Olszowska E., Olszowski S. and Zgliczyński J. M. (1991): Enhancement of immunogenic properties of ovalbumin as a result of its chlorination. Int. J. Biochem., 23, 1393-1395.
12. Marcinkiewicz J., Olszowska E., Olszowski S. and Zgliczyński J. M. (1992): Enhancement of trinitrophenyl-specific humoral response to TNP proteins as a result of carrier chlorination. Immunology, 76, 385-388.
13. Mauri C., Williams O. R., Walmsley M. and Feldmann M. (1996): Relationship between Th1/Th2 cytokine patterns and the arthritogenic response in collagen-induced arthritis. Eur. J. Immunol., 26, 1511-1518.
14. Myers L. K., Brand D. D., Ye X. J., Cremer M. A., Rosloniec E. F., Bodo M., Myllyharju J., Helaakoski T., Nokelainen M., Pihlajaniemi T., Kivirikko K., Yang C. L., Ala-Kokko L., Prockop D. J., Notbohm H., Fietzek P., Stuart J. M. and Kang A. H. (1998): Characterization of recombinant type II collagen: arthritogenicity and tolerogenicity in DBA/1 mice. Immunology, 95, 631-639.
15. Myers L. K., Seyer M. J., Stuart J. M. and Kang A. H. (1997): Suppression of murine collagen-induced arthritis by nasal administration of collagen. Immunology, 90, 161-164.
16. Myers L. K., Seyer M. J., Stuart J. M., Terato K., David C. S. and Kang A. H. (1993): T cell epitopes of type II collagen that regulate murine collagen-induced arthritis. J. Immunol., 151, 500-505.
17. Myers L. K., Stuart J. M. and Kang A. H. (1989): A CD4 cell is capable of transferring suppression of collagen-induced arthritis. J. Immunol., 143, 3976-3980.
18. Myers L. K., Stuart J. M., Seyer M. J. and Kang A. H. (1989): Identification of an immunosuppressive epitope of type II collagen that confers protection against collagen-induced arthritis. J. Exp. Med., 170, 1999-2010.
19. Naskalski J., Marcinkiewicz J. and Drożdż R. (2002): Myeloperoxidase-mediated protein oxidation: its possible biological functions. Clin. Chem. Lab. Med., 40, 463-468.
20. Olszowska E., Olszowski S., Zgliczyński J. M. and Stelmaszyńska T. (1989) Enhancement of proteinase-mediated degradation of proteins modified by chlorination. Int. J. Biochem., 21, 799-805.
21. Olszowski S., Mak P., Olszowska E. and Marcinkiewicz J. (2003): Collagen type II modification by hypochlorite. Acta Biochim. Pol., 50, 471-479.
22. Olszowski S., Olszowska E., Stelmaszyńska T., Krawczyk A., Marcinkiewicz J. and Baczek N. (1996): Oxidative modification of albumin. Acta. Biochim. Pol., 43, 661-672.
23. + flux. Nature, 21, 291-297.
24. Stuart J. M., Cremmer M. A., Townes A. S. and Kang A. H. (1982): Type II collagen induced arthritis in rats: passive transfer with serum and evidence that IgG anticollagen antibodies can cause arthritis. J. Exp. Med., 155, 1-16.
25. Trentham D. E. (1982): Collagen arthritis as a relevant model for rheumatoid arthritis. Arthritis Rheum., 25, 911-916.
26. Van Den Steen P. E., Proost P., Grillet B., Brand D. D., Kang A. H., Van Damme J. and Opdenakker G. (2002): Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis. FEBS, 16, 379-389.
27. Weiss S. J. (1989): Tissue destruction by neutrophils. N. Engl. J. Med., 320, 365-376.
28. Weissmann G. (1982): Activation of neutrophils and the lesions of rheumatoid arthritis. J. Lab. Clin. Med., 100, 322-333.